Liver regional continuous chemotherapy: Use of femoral or subclavian artery for percutaneous implantation of catheter-port systems

World Journal of Gastroenterology

Volumn 10, Issue 11, 2004, Pages 1659-1662

  Zhu, An Long ^a   Liu, Lian Xin ^a   Piao, Da Xun ^a   Lin, Yan Xin ^b   Zhao, Jin Peng ^a   Jiang, Hong Chi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Province Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; HEPARIN; UROKINASE;

ADULT; AGED; ARTERY CATHETER; ARTERY CATHETERIZATION; ARTERY EMBOLISM; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEVICE INFECTION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DYSESTHESIA; FEASIBILITY STUDY; FEMALE; FEMORAL ARTERY; HEMATOMA; HUMAN; IMMOBILIZATION; INTERMETHOD COMPARISON; LIVER CANCER; MALE; PAIN; SAFETY; SUBCLAVIAN ARTERY; SURGICAL TECHNIQUE; THORAX WALL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 2942726484     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i11.1659     Document Type: Article

References (31)

1. de Takats PG, Kerr DJ, Poole CJ, Warren HW, McArdle CS. Hepatic arterial chemotherapy for metastatic colorectal carcinoma. Br J Cancer 1994; 69: 372-378
2. Sterchi JM. Hepatic artery infusion for metastatic neoplastic disease. Surg Gynecol Obstet 1985; 160: 477-489
3. Hohn DC, Stagg RJ, Friedman MA, Hannigan JF Jr, Rayner A, Ignoffo RJ, Acord P, Lewis BJ. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989; 7: 1646-1654
4. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-693
5. Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Cancer 1994; 73: 1134-1142
6. Link KH, Sunelaitis E, Kornmann M, Schatz M, Gansauge F, Leder G, Formentini A, Staib L, Pillasch J, Beger HG. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival. Cancer 2001; 92: 2746-2753
7. Strecker EP, Ostheim-Dzerowycz W, Boos IB. Intraarterial infusion therapy via a subcutaneous port for limb-threatening ischemia: a pilot study. Cardiovasc Intervent Radiol 1998; 21: 109-115
8. Oberfield RA, McCaffrey JA, Polio J, Clouse ME, Hamilton T. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 1979; 44: 414-423
9. Ekberg H, Tranberg KG, Lundstedt C, Hanff G, Ranstam J, Jeppsson B, Bengmark S. Determinants of survival after intraarterial infusion of 5-fluorouracil for liver metastases from colorectal cancer: a multivariate analysis. J Surg Oncol 1986; 31: 246-254
10. Okuyama K, Tohnosu N, Koide Y, Awano T, Matsubara H, Sano T, Nakaichi H, Funami Y, Matsushita K, Kikuchi T. Complications and their management in intraarterial infusion chemotherapy. Gan To Kagaku Ryoho 1992; 19: 1007-1013
11. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-1260
12. Laffer U, Durig M, Bloch HR, Zuber M, Stoll HR. Implantable catheter systems. Experience with 205 patients. Dtsch Med Wochenschr 1989; 114: 655-658
13. Germer CT, Boese-Landgraf J, Albrecht D, Wagner A, Wolf KJ, Buhr HJ. The fully implantable minimally invasive hepatic artery catheter for locoregional chemotherapy of nonresectable liver metastases in defective conventional implanted therapy catheters. Chirurg 1996; 67: 458-462
14. Kuroiwa T, Honda H, Yoshimitsu K, Irie H, Aibe H, Shinozaki K, Nishie A, Nakayama T, Masuda K. A safe and simple method of percutaneous transfemoral implantation of a port-catheter access system for hepatic artery chemotherapy infusion. Gan To Kagaku Ryoho 2001; 28: 1573-1577
15. Pullyblank AM, Carey PD, Pearce SZ, Tanner AG, Guillou PJ, Monson JR. Comparison between peripherally implanted ports and externally sited catheters for long-term venous access. Ann R Coll Surg Engl 1994; 76: 33-38
16. Harvey WH, Pick TE, Reed K, Solenberger RI. A prospective evaluation of the Port-A-Cath implantable venous access system in chronically ill adults and children. Surg Gynecol Obstet 1989; 169: 495-500
17. Civalleri D, Cafiero F, Cosimelli M, Craus W, Doci R, Repetto M, Simoni G. Regional arterial chemotherapy of liver tumours. I. Performance comparison between a totally implantable pump and a conventional access system. Eur J Surg Oncol 1986; 12: 277-282
18. Huk I, Entscheff P, Prager M, Schulz F, Polterauer P, Funovics J. Patency rate of implantable devices during long-term intraarterial chemotherapy. Angiology 1990; 41: 936-941
19. Ross MN, Haase GM, Poole MA, Burrington JD, Odom LF. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 1988; 167: 141-144
20. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982; 92: 706-712
21. Wopfner F. Treatment of inoperable liver metastases: preliminary results with intrahepatic chemotherapy via a new type of indwelling catheter (author's transl). Dtsch Med Wochenschr 1981; 106: 1099-1102
22. Balch CM, Urist MM, McGregor ML. Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. A feasibility study in 50 patients. Am J Surg 1983; 145: 285-290
23. Buchwald H, Grage TB, Vassilopoulos PP, Rohde TD, Varco RL, Blackshear PJ. Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 1980; 45: 866-869
24. Dresing K, Lottner C, Stock W. Port-catheter perforation into the duodenum and other early complications after port implantation before intra-arterial infusion therapy of the liver with chemotherapeutic drugs. Med Klin 1991; 86: 245-250
25. al-Hathal M, Malmfors G, Garwicz S, Bekassy AN. Port-A-Cath in children during long-term chemotherapy: complications and outcome. Pediatr Hematol Oncol 1989; 6: 17-22
26. Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 1986; 57: 465-470
27. Strecker EP, Boos IB, Ostheim-Dzerowycz W, Heber R, Vetter SC. Percutaneously implantable catheter-port system: preliminary technical results. Radiology 1997; 202: 574-577
28. Fuchs R, Leimer L, Koch G, Westerhausen M. Clinical experience with bacterial contamination of Port-A-Cath systems in tumor patients. Dtsch Med Wochenschr 1987; 112: 1615-1618
29. Zanon C, Grosso M, Zanon E, Veltri A, Alabiso O, Bazzan M, Chiappino I, Mussa A. Transaxillary access to perform hepatic artery infusion (HAI) for secondary or primitive hepatic tumors. Minerva Chir 1996; 51: 755-758
30. Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, Greco FA, Huberman M, Moore C. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112: 423-428
31. Doughty JC, Keogh G, McArdle CS. Methods of replacing blocked hepatic artery catheters. Br J Surg 1997; 84: 618-619